Search all trials

Find therapies in clinical trials near you – page 51

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Mantle cell lymphoma recurrent+1

Recruiting

Registered drugNo placebo

A study to compare glofitamab against a drug combination for patients with relapsed or refractory mantle cell lymphoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Glofitamab

Contact Research Centre

Infertility female

Recruiting

Registered drugNo placebo

A study of progesterone after letrozole treatment for women with infertility undergoing intrauterine insemination

Registered drugNo placebo

Denmark

Participants:18–64 years
Substances:Progesterone

Contact Research Centre

Hormone-refractory prostate cancer

Recruiting

Registered drugNo placebo

A study of JNJ-78278343 and docetaxel compared to docetaxel and prednisone in patients with metastatic castration-resistant prostate cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Docetaxel

Contact Research Centre

Angelman's syndrome

Recruiting

InvestigationalNo placebo

A Phase 3 study to evaluate the efficacy and safety of ION582 in children and adults with Angelman syndrome

InvestigationalNo placebo

Germany

Participants:0–17 years · 18–64 years
Substances:2'-O-(2-Methoxyethyl) Modified Antisense Oligonucleotide Targeting Ube3A Antisense Transcript Rna

Contact Research Centre

Kidney transplant rejection

Recruiting

InvestigationalNo placebo

A study of allogeneic adipose-derived mesenchymal stem cells for the treatment of chronic active antibody-mediated rejection in kidney transplant recipients

InvestigationalNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:ALLOGENEIC ADIPOSE-DERIVED MESENCHYMAL STEM CELLS IN VITRO EXPANDED

Contact Research Centre

Sexually transmitted disease

Recruiting

Registered drugNo placebo

A study to compare weekly or event-based use of doxycycline to prevent sexually transmitted infections in men who have sex with men and transgender women using HIV prevention medication.

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Doxycycline

Contact Research Centre

Diabetic retinal oedema

Recruiting

Registered drugNo placebo

A study to compare the efficacy and safety of AVT29 and aflibercept in patients with diabetic macular edema

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Aflibercept

Contact Research Centre

Hormone-refractory prostate cancer+1

Recruiting

Registered drugNo placebo

A study evaluating the efficacy and safety of inavolisib and enzalutamide in patients with metastatic castration-resistant prostate cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Abiraterone

Contact Research Centre

Systemic scleroderma+4

Recruiting

InvestigationalNo placebo

A long-term safety study of KYV-101 in patients previously treated for lupus nephritis, systemic sclerosis, myasthenia gravis, rheumatoid arthritis, or stiff person syndrome

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Kyv-101

Contact Research Centre

Peripheral arterial occlusive disease+5

Recruiting

Registered drug

A study comparing one month versus one year of aspirin and clopidogrel treatment in patients with chronic limb-threatening ischemia after below-the-knee vascular therapy.

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Clopidogrel

Contact Research Centre

Chronic kidney disease

Recruiting

Registered drug

Study of the effect of empagliflozin on protein levels in the urine for patients with type 2 diabetes and kidney disease.

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Empagliflozin

Contact Research Centre

Hormone-refractory prostate cancer

Recruiting

Registered drugNo placebo

Study of AMO959, lutetium (177Lu) vipivotide tetraxetan, and a drug combination for adults with advanced prostate cancer.

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Abiraterone

Contact Research Centre

Find therapies in clinical trials near you – page 51

10 273 trials match your criteria

Mantle cell lymphoma recurrent+1

A study to compare glofitamab against a drug combination for patients with relapsed or refractory mantle cell lymphoma

Infertility female

A study of progesterone after letrozole treatment for women with infertility undergoing intrauterine insemination

Hormone-refractory prostate cancer

A study of JNJ-78278343 and docetaxel compared to docetaxel and prednisone in patients with metastatic castration-resistant prostate cancer

Angelman's syndrome

A Phase 3 study to evaluate the efficacy and safety of ION582 in children and adults with Angelman syndrome

Kidney transplant rejection

A study of allogeneic adipose-derived mesenchymal stem cells for the treatment of chronic active antibody-mediated rejection in kidney transplant recipients

Sexually transmitted disease

A study to compare weekly or event-based use of doxycycline to prevent sexually transmitted infections in men who have sex with men and transgender women using HIV prevention medication.

Diabetic retinal oedema

A study to compare the efficacy and safety of AVT29 and aflibercept in patients with diabetic macular edema

Hormone-refractory prostate cancer+1

A study evaluating the efficacy and safety of inavolisib and enzalutamide in patients with metastatic castration-resistant prostate cancer

Systemic scleroderma+4

A long-term safety study of KYV-101 in patients previously treated for lupus nephritis, systemic sclerosis, myasthenia gravis, rheumatoid arthritis, or stiff person syndrome

Peripheral arterial occlusive disease+5

A study comparing one month versus one year of aspirin and clopidogrel treatment in patients with chronic limb-threatening ischemia after below-the-knee vascular therapy.

Chronic kidney disease

Study of the effect of empagliflozin on protein levels in the urine for patients with type 2 diabetes and kidney disease.

Hormone-refractory prostate cancer

Study of AMO959, lutetium (177Lu) vipivotide tetraxetan, and a drug combination for adults with advanced prostate cancer.

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.